These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24461301)

  • 81. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
    Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T; Ito S; Aoyama M; Takeda Y; Suzumura H; Nakata K; Yamada Y; Suzuki S; Fukutomi T; Itoh M
    Eur J Pharmacol; 2001 Jan; 412(2):145-53. PubMed ID: 11165226
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
    Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.
    Yasunari K; Maeda K; Nakamura M; Watanabe T; Yoshikawa J; Asada A
    Am J Med; 2004 Apr; 116(7):460-5. PubMed ID: 15047035
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Is it time to replace propranolol with carvedilol for portal hypertension?
    Abid S; Ali S; Baig MA; Waheed AA
    World J Gastrointest Endosc; 2015 May; 7(5):532-9. PubMed ID: 25992192
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography.
    McDonald N; Lilburn DML; Lachlan NJ; Macnaught G; Patel D; Jayaswal ANA; Hayes PC; Semple SI; Fallowfield JA
    Biomed Res Int; 2017; 2017():9281450. PubMed ID: 28698881
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.
    Chen S; Wang JJ; Wang QQ; Hu JW; Dong S; Hu LJ; Jian YC; Liu XY; Yang GM; Xiong WJ
    Patient Prefer Adherence; 2015; 9():961-70. PubMed ID: 26203230
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Carvedilol: the β-blocker of choice for portal hypertension?
    Bosch J
    Gut; 2013 Nov; 62(11):1529-30. PubMed ID: 23355548
    [No Abstract]   [Full Text] [Related]  

  • 93. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
    Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
    J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long-term pharmacologic therapy of portal hypertension.
    Burroughs AK; McCormick PA
    Surg Clin North Am; 1990 Apr; 70(2):319-39. PubMed ID: 1969683
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    Acta Med Scand Suppl; 1985; 693():115-20. PubMed ID: 2859739
    [TBL] [Abstract][Full Text] [Related]  

  • 97. β-Blockers Improve Presinusoidal Portal Hypertension.
    Sørensen M; Larsen LP; Villadsen GE; Aagaard NK; Grønbæk H; Keiding S; Vilstrup H
    Dig Dis Sci; 2018 Nov; 63(11):3153-3157. PubMed ID: 30003386
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
    Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
    Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
    Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2318-2326.e7. PubMed ID: 35842118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.